Texas Oncology-DFW is a clinical research site located in Dallas, Texas, United States 75246.
Crixeo Clinical Trials Trust Score: 29/100 (FAILING). This profile has not yet been claimed by the site owner.
Texas Oncology-DFW has participated in 64 clinical trials with 59 currently active.
Therapeutic areas: Limited Stage Small Cell Lung Cancer, Melanoma, Non-small Cell Lung Cancer.
Sponsors: SCRI Development Innovations, LLC, Seagen, a wholly owned subsidiary of Pfizer, Eli Lilly and Company.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Texas · View every site in Dallas
Trust Score: 29/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Texas Oncology-DFW has a Crixeo Trust Score of 29/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Texas Oncology-DFW has 64 clinical trials on record, with 59 currently active. Their work covers Limited Stage Small Cell Lung Cancer, Melanoma, Non-small Cell Lung Cancer.
Texas Oncology-DFW has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.